H.C. Wainwright Reiterates Buy Rating on Arcturus Therapeutics (ARCT)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| AMERICAN RCT REIT (NASDAQ: ARCT) | Delayed: 9.84 -0.89 (8.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.73 | 52 Week High | $13.09 | |||
| Open | $10.59 | 52 Week Low | $5.54 | |||
| Day High | $10.69 | P/E | N/A | |||
| Day Low | $9.75 | EPS | $-0.38 | |||
| Volume | 474,965 | |||||
